<p>New Delhi: India's long-distance runner Archana Jadhav was on Tuesday banned for four years owing to a failed dope test in January, the findings of which she did not contest despite repeated reminders, prompting World Athletics to deem her actions as acceptance of guilt.</p>.<p>According to World Athletics' Athletes Integrity Unit (AIU), Jadhav's sample, which was collected at the Pune Half-Marathon in December last year, contained prohibited substance Oxandrolone. This synthetic anabolic steroid promotes protein production and muscle building in the body.</p>.<p>The ban came into effect from January 7. Jadhav has been under provisional suspension for the duration. On February 25, she had replied to the violation charge in an e-mail to the AIU stating "I am extremely sorry sir...I welcome your decision." The AIU said its understanding of this communication was that Jadhav did not require a hearing and was "content" to get a decision from the body.</p>.Chelsea forward Mykhailo Mudryk in shock after adverse anti-doping test.<p>The AIU said Jadhav was nonetheless informed that she had time till March 3 to admit that she had committed the Anti-Doping Rule Violations, and was reminded of the same by the Athletics Federation of India (AFI) on February 28. The AIU, however, did not get any response from Jadhav.</p>.<p>The AIU said Jadhav has also not demonstrated that the Anti-Doping Rule Violations were "not intentional".</p>.<p>"...the Athlete is deemed to have committed the Anti-Doping Rule Violations...," the AIU stated.</p>.<p>As a result, "a period of ineligibility of four years" commences on January 7.</p>.<p>In addition, her results on and since December 15, 2024 stand disqualified.</p>.<p>She will have to forfeit all awards, medals, points, prizes and appearance money for the period.</p>.<p>The AIU said Jadhav did not exercise her right to a 'B' sample test despite expressing a desire to do so in early communication.</p>.<p>She responded well past the stipulated date of January 17 to state that she was hospitalised owing to illness.</p>.<p>This was after she was told about the procedure and the cost involved in getting a test. The AIU said it had provided an extended deadline to the athlete.</p>.<p>"...on 22 January 2025, the AIU wrote to the Athlete and provided her with an extended deadline by which to make the full payment of the costs of the B Sample analysis to World Athletics..." Jadhav was required to confirm her availability by no later than January 24.</p>.<p>The AIU said Jadhav once again failed to respond or make the full payment.</p>.<p>She had last competed in the Delhi half marathon in October 2024 in the elite Indian women's race, finishing fourth with a time of 1:20.21 behind winner Lili Das, Kavita Yadav and Priti Lamba.</p>.<p>Jadhav has a personal best of 35:44.26 in 10,000m, and 1:20:21 in the half marathon. In the 3,000m, she has a personal best of 10:28.82.</p>.<p>Jadhav had also submitted reports from Agilus Diagnostics containing the results of several (negative) drug tests performed on a urine sample. </p>
<p>New Delhi: India's long-distance runner Archana Jadhav was on Tuesday banned for four years owing to a failed dope test in January, the findings of which she did not contest despite repeated reminders, prompting World Athletics to deem her actions as acceptance of guilt.</p>.<p>According to World Athletics' Athletes Integrity Unit (AIU), Jadhav's sample, which was collected at the Pune Half-Marathon in December last year, contained prohibited substance Oxandrolone. This synthetic anabolic steroid promotes protein production and muscle building in the body.</p>.<p>The ban came into effect from January 7. Jadhav has been under provisional suspension for the duration. On February 25, she had replied to the violation charge in an e-mail to the AIU stating "I am extremely sorry sir...I welcome your decision." The AIU said its understanding of this communication was that Jadhav did not require a hearing and was "content" to get a decision from the body.</p>.Chelsea forward Mykhailo Mudryk in shock after adverse anti-doping test.<p>The AIU said Jadhav was nonetheless informed that she had time till March 3 to admit that she had committed the Anti-Doping Rule Violations, and was reminded of the same by the Athletics Federation of India (AFI) on February 28. The AIU, however, did not get any response from Jadhav.</p>.<p>The AIU said Jadhav has also not demonstrated that the Anti-Doping Rule Violations were "not intentional".</p>.<p>"...the Athlete is deemed to have committed the Anti-Doping Rule Violations...," the AIU stated.</p>.<p>As a result, "a period of ineligibility of four years" commences on January 7.</p>.<p>In addition, her results on and since December 15, 2024 stand disqualified.</p>.<p>She will have to forfeit all awards, medals, points, prizes and appearance money for the period.</p>.<p>The AIU said Jadhav did not exercise her right to a 'B' sample test despite expressing a desire to do so in early communication.</p>.<p>She responded well past the stipulated date of January 17 to state that she was hospitalised owing to illness.</p>.<p>This was after she was told about the procedure and the cost involved in getting a test. The AIU said it had provided an extended deadline to the athlete.</p>.<p>"...on 22 January 2025, the AIU wrote to the Athlete and provided her with an extended deadline by which to make the full payment of the costs of the B Sample analysis to World Athletics..." Jadhav was required to confirm her availability by no later than January 24.</p>.<p>The AIU said Jadhav once again failed to respond or make the full payment.</p>.<p>She had last competed in the Delhi half marathon in October 2024 in the elite Indian women's race, finishing fourth with a time of 1:20.21 behind winner Lili Das, Kavita Yadav and Priti Lamba.</p>.<p>Jadhav has a personal best of 35:44.26 in 10,000m, and 1:20:21 in the half marathon. In the 3,000m, she has a personal best of 10:28.82.</p>.<p>Jadhav had also submitted reports from Agilus Diagnostics containing the results of several (negative) drug tests performed on a urine sample. </p>